scPharmaceuticals Inc. - stock earnings
SCPH Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 8, 2024 AfterMarket | - / -0.4457000000 | - | - / 6.1 million | - |
SCPH Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -13.8 million USD | 6.1 million USD |
| 2023Q3 | -15.6 million USD | 3.8 million USD |
| 2023Q2 | -14.2 million USD | 1.6 million USD |
| 2023Q1 | -12.8 million USD | 2.1 million USD |
| 2022Q4 | -9.8 million USD | ? USD |
| 2022Q3 | -10.3 million USD | ? USD |
| 2022Q2 | -10.0 million USD | ? USD |
| 2022Q1 | -8.2 million USD | ? USD |
| 2021Q4 | -7.3 million USD | ? USD |
| 2021Q3 | -6.6 million USD | ? USD |
| 2021Q2 | -7.1 million USD | ? USD |
| 2021Q1 | -7.1 million USD | ? USD |
| 2020Q4 | -7.8 million USD | ? USD |
| 2020Q3 | -9.0 million USD | ? USD |
| 2020Q2 | -8.3 million USD | ? USD |
| 2020Q1 | -7.1 million USD | ? USD |
| 2019Q4 | -10.8 million USD | ? USD |
| 2019Q3 | -6.2 million USD | ? USD |
| 2019Q2 | -7.3 million USD | ? USD |
| 2019Q1 | -8.7 million USD | ? USD |
| 2018Q4 | -5.1 million USD | ? USD |
| 2018Q3 | -5.8 million USD | ? USD |
| 2018Q2 | -9.9 million USD | ? USD |
| 2018Q1 | -8.7 million USD | ? USD |
| 2017Q4 | -6.9 million USD | ? USD |
| 2017Q3 | -5.5 million USD | ? USD |
| 2017Q2 | -6.5 million USD | ? USD |
| 2017Q1 | -4.9 million USD | ? USD |
| 2016Q4 | -5.3 million USD | ? USD |
| 2015Q4 | -10.5 million USD | ? USD |
SCPH Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -54.8 million USD | 13.6 million USD |
| 2022 | -37.5 million USD | 2.1 million USD |
| 2021 | -30.5 million USD | ? USD |
| 2020 | -34.4 million USD | ? USD |
| 2019 | -34.4 million USD | ? USD |
| 2018 | -29.4 million USD | ? USD |
| 2017 | -23.8 million USD | ? USD |
| 2016 | -24.4 million USD | ? USD |
| 2015 | -10.5 million USD | ? USD |
SCPH
Price: $4.90
52 week price:
Earnings Per Share: -1.42 USD
P/E Ratio: -4.15
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 152000
Market Capitalization: 176.7 million